Voxel-based dosimetry with integrated Y-90 PET/MRI and prediction of response of primary and metastatic liver tumors to radioembolization with Y-90 glass microspheres.

MLA

Demir, Burak, et al. “Voxel-Based Dosimetry with Integrated Y-90 PET/MRI and Prediction of Response of Primary and Metastatic Liver Tumors to Radioembolization with Y-90 Glass Microspheres.” Annals of Nuclear Medicine, vol. 39, no. 1, Jan. 2025, pp. 31–46. EBSCOhost, https://doi.org/10.1007/s12149-024-01974-w.

APA

Demir, B., Soydal, C., Kucuk, N. O., Celebioglu, E. C., Bilgic, M. S., Kuru Oz, D., Elhan, A. H., & Kir, K. M. (2025). Voxel-based dosimetry with integrated Y-90 PET/MRI and prediction of response of primary and metastatic liver tumors to radioembolization with Y-90 glass microspheres. Annals of Nuclear Medicine, 39(1), 31–46. https://doi.org/10.1007/s12149-024-01974-w

Chicago

Demir, Burak, Cigdem Soydal, Nuriye Ozlem Kucuk, Emre Can Celebioglu, Mehmet Sadık Bilgic, Digdem Kuru Oz, Atilla Halil Elhan, and Kemal Metin Kir. 2025. “Voxel-Based Dosimetry with Integrated Y-90 PET/MRI and Prediction of Response of Primary and Metastatic Liver Tumors to Radioembolization with Y-90 Glass Microspheres.” Annals of Nuclear Medicine 39 (1): 31–46. doi:10.1007/s12149-024-01974-w.